TipRanks
Go Ultimate55% OFF

Compare Crispr Therapeutics AG (1CG) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:1CGCrispr Therapeutics AGEUR 46.14EUR 4.45B-10.80-12.11%Moderate BuyUnlock the DE:1CG analyst price target with TipRanks PremiumDE:1CGUnlock the DE:1CG top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$12.47$1.75B-3.711.67%Moderate BuyUnlock the NTLA analyst price target with TipRanks PremiumDE:1CG vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
BEAMBeam Therapeutics$27.23$2.81B-33.2114.41%Strong BuyUnlock the BEAM analyst price target with TipRanks PremiumDE:1CG vs BEAMUnlock the BEAM top-analyst price target with TipRanks Premium
LEGNLegend Biotech$21.63$4.19B-43.26-32.93%Moderate BuyUnlock the LEGN analyst price target with TipRanks PremiumDE:1CG vs LEGNUnlock the LEGN top-analyst price target with TipRanks Premium
KYMRKymera Therapeutics$126.63$10.81B-34.88106.10%Strong BuyUnlock the KYMR analyst price target with TipRanks PremiumDE:1CG vs KYMRUnlock the KYMR top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:1CGCrispr Therapeutics AG46.14-8.86-16.11%
NTLAIntellia Therapeutics12.47-0.60-4.59%
BEAMBeam Therapeutics27.232.9812.29%
LEGNLegend Biotech21.63-10.50-32.68%
KYMRKymera Therapeutics126.6366.91112.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts